Victory Square Technologies Portfolio Company Enters Into a Distribution & Testing Agreement With the Canadian Police Association to Provide Safetest Covid-19 Testing Kits & On-Site Testing Services to Over 60,000 Members in Canada
The Canadian Police Association represents over 60,000 police personnel serving in 160 police services across Canada
Victory Square Health will offer Safetest Covid-19 Testing Kits, on-site testing professionals and diagnostics to the Canadian Police Association following Health Canada approvalsAssisting Front Line Heroes is a priority for Victory Square Health
VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) — Victory Square Health Inc. (“VS Health” or the “Company”) – a portfolio company of Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) — is pleased to announce that it has entered into a partnership agreement to provide Safetest Covid-19 Testing Kits to the Canadian Police Association representing 60,000 active police members who serve from coast to coast in Canada. This is subject to Health Canada approval.The Canadian Police Association (CPA) is the national voice for 60,000 police personnel across Canada. Membership includes police personnel serving in 160 police services from Canada’s smallest towns and villages as well as those working in Canada’s largest municipal and provincial police services, and railway police. The Association also has an affiliation with court personnel, jail guards and First Nations’ police and service personnel across the country. Through the Canadian Police Association; the offer for Victory Square testing kits & services will be made to the RCMP (Royal Canadian Mounted Police) and its additional more than 20,000 law enforcement members across Canada.This distribution agreement will enable Victory Square Health to support the Canadian Police Association as they continue to keep all Canadian’s safe during these unprecedented times. The Canadian Police Association’s 60,000 members who serve on the front lines will be equipped to receive Covid-19 test results in a much quicker fashion with the Safetest suite of products. Victory Square Health will also offer software and end-to-end encryption protocols to the Association as well as on-site testing professionals and diagnostics as requested following Health Canada approvals.“We are very pleased to work with Victory Square,” said Canadian Police Association President Tom Stamatakis. “We believe that the Victory Square Covid-19 Safetest products and on-site testing services will be a critical piece to ensuring the safety of our officers who wear the badge and serve and protect us across Canada,” said Stamatakis. “The Safetest Covid-19 products and testing will be made available for wide distribution as well as one-stop testing and on-site analysis by Victory Square to our members following Health Canada approvals.”“We are very delighted to enter into a distribution and testing agreement with The Canadian Police Association and its more than 60,000 heroes who wear the badge to keep our cities and communities safe, along with its members in the justice, and jail system across the country,” said Victory Square CEO Shafin Diamond Tejani. “We are pleased to offer the first responders, and organizations with our exclusive Safetest products and services in their plight to ensure that their front-line personnel are kept safe and informed during this pandemic.”Victory Square Health is also proud to step up and assist our Heroes who wear the badge by providing complimentary Safetest Covid-19 testing to all family members of police officers who test positive for the virus.VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient’s care and improve health outcomes. Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D pipelines of diagnostic kits for Hansen’s Disease, Brucellosis, HTLV and Blood samples screening tests.Disclaimer:The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.Check out VictorySquare.com and sign up to VST’s official newsletter at www.VictorySquare.com/newsletter.On behalf of the board,Shafin Diamond TejaniChief Executive OfficerVictory Square TechnologiesFor further information about the Company, please contact:Investor Relations Contact – Alex TziliosEmail: firstname.lastname@example.orgTelephone: 778-867-0482Media Relations Contact – Howard Blank, DirectorEmail: email@example.comTelephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.VST’s sweet spot is the cutting-edge tech that’s shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startupsVST isn’t just another investor. With real skin in the game, we’re committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you’ll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they’re unicorns.Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.Forward Looking StatementThis news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.